SCHEMBL10167009

SCHEMBL10167009

C#CCN(c1ccc(S(=O)(=O)c2ccccc2)cc1Br)S(=O)(=O)CCl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.34
HTR6 P50406 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA4 P22748 2/20 0.33
CA9 Q16790 2/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
CA7 P43166 1/20 0.33
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
HTR2C P28335 2/20 0.31
ESR1 P03372 2/20 0.31
HTR2A P28223 1/20 0.31
KCNH2 Q12809 1/20 0.31
HTR2B P41595 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167025 0.86 HTR2A (0.36) TYMSHTR6SMN1; SMN2ALDH1A1POLB
SCHEMBL10167015 0.73 RORC (0.38) TYMSHTR6SMN1; SMN2ALDH1A1POLB
SCHEMBL10787329 0.72 CA12 (0.37) SMN1; SMN2CA12CA1CA2CA4
SCHEMBL10167019 0.71 HTR2A (0.37) TYMSHTR6SMN1; SMN2ALDH1A1POLB
SCHEMBL10206323 0.68 CA2 (0.41) HTR6SMN1; SMN2CA12CA1CA2
SCHEMBL10167016 0.67 NR1H3 (0.43) HTR6SMN1; SMN2ALDH1A1POLBMAPT
SCHEMBL7206333 0.66 HTR6 (0.58) HTR6SMN1; SMN2CA12CA1CA2
SCHEMBL8471385 0.65 ALDH1A1 (0.64) HTR6SMN1; SMN2ALDH1A1POLBMAPT
SCHEMBL2908734 0.62 HTR6 (0.52) HTR6SMN1; SMN2ALDH1A1POLBMAPT
SCHEMBL3145465 0.62 HTR6 (0.52) HTR6SMN1; SMN2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8692001-B2 Sulfonamides for the modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2014-04-08 US disclosed
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 PDK1, PDK4, PDK2 TYMS 186/4885HTR6 3843/4885SMN1; SMN2 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.